Exact Mass: 173.1579692

Exact Mass Matches: 173.1579692

Found 138 metabolites which its exact mass value is equals to given mass value 173.1579692, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Norselegiline

n-[(2r)-1-Phenylpropan-2-yl]prop-2-yn-1-amine

C12H15N (173.120443)

D004791 - Enzyme Inhibitors > D008996 - Monoamine Oxidase Inhibitors

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine

C12H15N (173.120443)

D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D009676 - Noxae > D009498 - Neurotoxins KEIO_ID M034

Indospicine

Heptanoic acid, 2,7-diamino-7-imino-

C7H15N3O2 (173.116421)

apo-[3-methylcrotonoyl-CoA:carbon-dioxide ligase (ADP-forming)]

C7H15N3O2 (173.116421)

Apo-[3-methylcrotonoyl-coa:carbon-dioxide ligase (adp-forming)] is part of the Biotin metabolism pathway. It is a substrate for: Biotin--protein ligase.

4-Piperidinol, 1-hydroxy-2,2,6,6-tetramethyl-

4-Hydroxy-2,2,6,6-tetramethyl-1-hydroxypiperidine

C9H19NO2 (173.1415714)

2,7-Diamino-7-iminoheptanoic acid

2-amino-6-carbamimidoylhexanoic acid

C7H15N3O2 (173.116421)

5-[(1-Iminoethyl)amino]-2-aminopentanoic acid

C7H15N3O2 (173.116421)

Bicifadine

1-(4-methylphenyl)-3-azabicyclo[3.1.0]hexane

C12H15N (173.120443)

n-[(2r)-1-Phenylpropan-2-yl]prop-2-yn-1-amine

C12H15N (173.120443)

n-iminoethyl-l-ornithine

5-amino-2-[(2-iminoethyl)amino]pentanoic acid

C7H15N3O2 (173.116421)

HMBOA trihexose

3-Methyl-2-(trimethylazaniumyl)pentanoic acid

C9H19NO2 (173.1415714)

4-Methyl-4-semicarbazido-pentan-2-on|4-methyl-4-semicarbazido-pentan-2-one|Diacetonsemicarbazid|Methyl-(beta-semicarbazino-isobutyl)-keton

C7H15N3O2 (173.116421)

1-[3-(Methylthio)propyl]-3-methylpyrrolidine

C9H19NS (173.1238134)

1-Butyl-1H-indole

C12H15N (173.120443)

Triacetoneamine hydrate

4-Piperidinone, 2,2,6,6-tetramethyl-, monohydrate

C9H19NO2 (173.1415714)

Nordeprenyl

Desmethylselegiline

C12H15N (173.120443)

D004791 - Enzyme Inhibitors > D008996 - Monoamine Oxidase Inhibitors CONFIDENCE standard compound; EAWAG_UCHEM_ID 3281 CONFIDENCE standard compound; INTERNAL_ID 2118

Desmethylselegiline

C12H15N (173.120443)

CONFIDENCE Transformation product with Reference Standard (Level 1); INTERNAL_ID 503 D004791 - Enzyme Inhibitors > D008996 - Monoamine Oxidase Inhibitors

Leucine propyl ester

C9H19NO2 (173.1415714)

3R-aminononanoic acid

Nonanoic acid, 3-amino-, (R)-

C9H19NO2 (173.1415714)

L-NIO

N5-(1-iminoethyl)-L-ornithine, dihydrochloride

C7H15N3O2 (173.116421)

(+)-Muscarine

2,5-anhydro-1,4,6-trideoxy-6-(trimethylammonio)-D-ribo-hexitol, iodide

C9H19NO2 (173.1415714)

9-amino-nonanoic acid

C9H19NO2 (173.1415714)

(2S)-6-amino-2-[(hydroxymethylidene)amino]hexanimidic acid

apo-[3-methylcrotonoyl-CoA:carbon-dioxide ligase (ADP-forming)]

C7H15N3O2 (173.116421)

b-Alanine, N,N-diethyl-, ethylester

C9H19NO2 (173.1415714)

[1-(2-methoxyethyl)piperidin-3-yl]methanol

C9H19NO2 (173.1415714)

CHEMBRDG-BB 4022075

C7H15N3O2 (173.116421)

PENTAMETHYLBENZONITRILE

C12H15N (173.120443)

2-(4-(tert-Butyl)phenyl)acetonitrile

C12H15N (173.120443)

2-(tert-butyl)indole

2-tert-Butyl-1H-indole

C12H15N (173.120443)

Benzonitrile, 4-pentyl-

C12H15N (173.120443)

dl-phenyl-d5-alanine-2,3,3-d3

C9H3D8NO2 (173.12919202400002)

1-CYCLOPROPYL-1,2,3,4-TETRAHYDRO-ISOQUINOLINE

C12H15N (173.120443)

1,3,3 TRIMETHYL-2-METHYLENE INDOLINE

C12H15N (173.120443)

9-aminononanoic acid

C9H19NO2 (173.1415714)

A omega-amino fatty acid that is nonanoic acid substituted by an amino group at position 9.

N,N-Bis[3-(methylamino)propyl]methylamine

C9H23N3 (173.18918779999998)

7-AMINO-HEPTANOIC ACID HCL ,98.0+

C9H19NO2 (173.1415714)

N-Methoxy-N-methylheptanamide

C9H19NO2 (173.1415714)

2-PHENYL-7-AZABICYCLO[2.2.1]HEPTANE

C12H15N (173.120443)

Nonanoic acid, 2-amino-

C9H19NO2 (173.1415714)

2,3,4,4a,9,9a-hexahydro-1H-carbazole

C12H15N (173.120443)

4-hydroxy-tempo

4-Piperidinol, 1-hydroxy-2,2,6,6-tetramethyl-

C9H19NO2 (173.1415714)

D020011 - Protective Agents > D011837 - Radiation-Protective Agents D020011 - Protective Agents > D000975 - Antioxidants

2-Dibutylaminoethanol

C10H23NO (173.17795479999998)

pentamethyldiethylenetriamine

1,1,4,7,7-Pentamethyldiethylenetriamine

C9H23N3 (173.18918779999998)

n-formylhexamethyleneimine dimethyl acetal

C9H19NO2 (173.1415714)

10-Amino-1-decanol

C10H23NO (173.17795479999998)

6-phenylhexanenitrile

C12H15N (173.120443)

4,4-diethoxypiperidine

C9H19NO2 (173.1415714)

tert-Butyl (2-amino-2-iminoethyl)carbamate

C7H15N3O2 (173.116421)

tert-Butyl 2-(1-iminoethyl)hydrazinecarboxylate

C7H15N3O2 (173.116421)

Bicifadine hydrochloride

C12H15N (173.120443)

N-[[4-(3-bromo-4-methoxy-phenyl)-1,3-thiazol-2-yl]thiocarbamoyl]-3-ethoxy-benzamide

C10H23NO (173.17795479999998)

N,N-DIMETHYLOCTYLAMINE-N-OXIDE

C10H23NO (173.17795479999998)

1-oxa-4,7,10-triazacyclododecane

C8H19N3O (173.15280439999998)

1,3,3-TriMethyl-3,4-dihydroisoquinoline

C12H15N (173.120443)

1-(1-phenylethenyl)pyrrolidine

C12H15N (173.120443)

Propanoic acid,3-(butylamino)-2-methyl-, methyl ester

C9H19NO2 (173.1415714)

3-MORPHOLIN-4-YL-PROPIONIC ACID HYDRAZIDE

C7H15N3O2 (173.116421)

2-((2-Methoxyethyl)amino)cyclohexanol

C9H19NO2 (173.1415714)

6-guanidinohexanoic acid

C7H15N3O2 (173.116421)

A member of the class of guanidines that consists of hexanoic acid substituted by a guanidino group at position 6.

n,n-diallylaniline

C12H15N (173.120443)

tert-Butyl L-valinate

C9H19NO2 (173.1415714)

[1-(2-methoxyethyl)piperidin-4-yl]methanol

C9H19NO2 (173.1415714)

2,3,3,5-Tetramethyl indolenine

C12H15N (173.120443)

1-Benzyl-1,2,3,6-tetrahydropyridine

C12H15N (173.120443)

4-(Dipropylamino)-1-butanol

C10H23NO (173.17795479999998)

2-Ethyl-2-phenylbutyronitrile

C12H15N (173.120443)

1H-1,2,3-Triazole,4,5-dihydro-1-methoxy-4,4,5,5-tetramethyl-,2-oxide(9CI)

C7H15N3O2 (173.116421)

1-Ethyl-3(3-Dimethylamino)Urea

C8H19N3O (173.15280439999998)

4-(PROPYLTHIO)ANILINE

C9H19NO2 (173.1415714)

2-phenylhexanenitrile

C12H15N (173.120443)

2-AMINO-3-ETHYL-HEPTANOIC ACID

C9H19NO2 (173.1415714)

4-Morpholinecarboximidamide, N-hydroxy-3,3-dimethyl-

C7H15N3O2 (173.116421)

1-FLUORO-2-METHYL-N,N-BIS(1-METHYLETHYL)-1-PROPEN-1-AMINE

C10H20FN (173.1579692)

2-TERT-BUTYL-INDOLIZINE

C12H15N (173.120443)

Ethanol,2-(octylamino)-

C10H23NO (173.17795479999998)

L-Phenylalanine-d8

C9H3D8NO2 (173.12919202400002)

4-(2-hydroxyethyl)-piperazine-1-carboxylic acid amide

C7H15N3O2 (173.116421)

3-Benzyl-3-azabicyclo[3.1.0]hexane

C12H15N (173.120443)

(3-MERCAPTOPROPYL)TRIMETHOXYSILANE

C9H19NO2 (173.1415714)

2-(4-butylphenyl)acetonitrile

C12H15N (173.120443)

l-norvaline t-butyl ester

C9H19NO2 (173.1415714)

4-(1-propenyl butenyl) pyridine

C12H15N (173.120443)

Julolidine

C12H15N (173.120443)

BENZENEACETONITRILE, 2,3,5,6-TETRAMETHYL-

C12H15N (173.120443)

N-a-Boc-D-2,4-Diaminobutyricacid

C9H19NO2 (173.1415714)

Imagabalin

C9H19NO2 (173.1415714)

C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

3-Butoxy-N,N-dimethylpropanamide

C9H19NO2 (173.1415714)

6-tert-Butylindole

C12H15N (173.120443)

4-(1-Cyclohexenyl)aniline

C12H15N (173.120443)

2,3,5,7-tetramethyl-1H-indole

C12H15N (173.120443)

(D-PEN2,P-CHLORO-PHE4,D-PEN5)-ENKEPHALIN

C12H15N (173.120443)

N,N-Diethyl-4-ethynylaniline

C12H15N (173.120443)

N,N-di-n-propyl-l-alanine

C9H19NO2 (173.1415714)

1-AMINO-3-CYCLOHEXYLOXY-PROPAN-2-OL

C9H19NO2 (173.1415714)

(2R)-2-Ammoniononanoate

C9H19NO2 (173.1415714)

2-AMINO-2-BUTYLHEXANOL

C10H23NO (173.17795479999998)

2-(2-(Piperidyl)ethoxy)ethanol

C9H19NO2 (173.1415714)

3-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

C12H15N (173.120443)

methyl 3-(diethylamino)-2-methylpropanoate

C9H19NO2 (173.1415714)

4-TERT-BUTYLBENZYLISOCYANIDE

C12H15N (173.120443)

2-[(2-ethylhexyl)amino]ethanol

C10H23NO (173.17795479999998)

Diisopropylaminotrimethylsilane

C9H23NSi (173.1599678)

4-n-butyl-2-methylbenzonitrile

C12H15N (173.120443)

8-DIMETHYLAMINO-1-OCTANOL

C10H23NO (173.17795479999998)

Hydrocitronitril

C12H15N (173.120443)

1,5-Pentanediamine, N-(4-aminobutyl)-

C9H23N3 (173.18918779999998)

4-(Aminomethyl)octane-1,8-diamine

C9H23N3 (173.18918779999998)

Argininamide

C6H15N5O (173.127654)

O-Decylhydroxylamine

C10H23NO (173.17795479999998)

2,4,4-Trimethyl-3,4-dihydroquinoline

C12H15N (173.120443)

5-(1-Hexynyl)-2-methylpyridine

C12H15N (173.120443)

N5-iminoethyl-L-ornithine

C7H15N3O2 (173.116421)

D004791 - Enzyme Inhibitors

1,2,3,7-Tetramethylindole

1,2,3,7-Tetramethyl-1H-indole

C12H15N (173.120443)

apo-[3-methylcrotonoyl-CoA:carbon-dioxide ligase (ADP-forming)]

C7H15N3O2 (173.116421)

Apo-[3-methylcrotonoyl-coa:carbon-dioxide ligase (adp-forming)] is a member of the class of compounds known as carboximidic acids. Carboximidic acids are organic acids with the general formula RC(=N)-OH (R=H, organic group). Apo-[3-methylcrotonoyl-coa:carbon-dioxide ligase (adp-forming)] is soluble (in water) and a very weakly acidic compound (based on its pKa). Apo-[3-methylcrotonoyl-coa:carbon-dioxide ligase (adp-forming)] can be found in barley, corn, and spinach, which makes apo-[3-methylcrotonoyl-coa:carbon-dioxide ligase (adp-forming)] a potential biomarker for the consumption of these food products. Apo-[3-methylcrotonoyl-coa:carbon-dioxide ligase (adp-forming)] is part of the Biotin metabolism pathway. It is a substrate for: Biotin--protein ligase.

2-Amino-5-(1-aminoethylideneamino)pentanoic acid

C7H15N3O2 (173.116421)

apo-[3-methylcrotonoyl-CoA:carbon-dioxide ligase (ADP-forming)]

C7H15N3O2 (173.116421)

Apo-[3-methylcrotonoyl-coa:carbon-dioxide ligase (adp-forming)] is part of the Biotin metabolism pathway. It is a substrate for: Biotin--protein ligase.